Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|March 28, 2014
The HCV Revolution Did Not Happen OvernightAnn D KwongAntimicrobial Agents and Chemotherapy|November 25, 2004
Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cellsKai Lin, Ann D Kwong, Chao LinNature Reviews. Drug Discovery|September 27, 2005
Viral and cellular RNA helicases as antiviral targetsAnn D Kwong, B Govinda Rao, Kuan-Teh JeangThe Journal of Antimicrobial Chemotherapy|November 12, 2009
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)Tara L Kieffer, Ann D Kwong, Gaston R PicchioCurrent Opinion in Pharmacology|October 7, 2008
Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitorsAnn D Kwong, Lindsay McNair, Ira Jacobson, et al.Nature Biotechnology|November 10, 2011
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virusAnn D Kwong, Robert S Kauffman, Patricia Hurter, et al.Antimicrobial Agents and Chemotherapy|April 28, 2006
VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cellsKai Lin, Robert B Perni, Ann D Kwong, et al.Antimicrobial Agents and Chemotherapy|July 10, 2013
Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrationsGururaj Kalkeri, Chao Lin, Jenna Gopilan, et al.Microbiology Spectrum|January 10, 2024
SARS-CoV-2 viral dynamics in a placebo-controlled phase 2 study of patients infected with the SARS-CoV-2 Omicron variant and treated with pomotrelvirKatyna Borroto-Esoda, David Wilfret, Xiao Tong, et al.Antiviral Research|November 12, 2017
Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogensXiao Tong, Jeanon Smith, Natalya Bukreyeva, et al.Pageof 3